Incidence of psychiatric illness in patients with neuroendocrine tumors: a comparative population-based analysis.
Carcinoid
Mental health
Neuroendocrine
Psychiatry
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
07
04
2022
accepted:
16
09
2022
pubmed:
6
10
2022
medline:
8
11
2022
entrez:
5
10
2022
Statut:
ppublish
Résumé
Diversion of tryptophan to tumoral hormonal production has been suggested to result in psychiatric illnesses in neuroendocrine tumors (NET). We measured the occurrence of psychiatric illness after NET diagnosis and compare it to colon cancer (CC). We conducted a population-based retrospective cohort study. Adults with NET were matched 1:1 to CC (2000-2019). Psychiatric illness was defined by mental health diagnoses and mental health care use after a cancer diagnosis, categorized as severe, other, and none. Cumulative incidence functions accounted for death as a competing risk. A total of 11,223 NETs were matched to CC controls. Five-year cumulative incidences of severe psychiatric illness for NETs vs. CC was 7.7% (95%CI 7.2-8.2%) vs 7.6% (95%CI 7.2-8.2%) (p = 0.50), and that of other psychiatric illness was 32.9% (95%CI 32.0-33.9%) vs 31.6% (95%CI 30.8-32.6%) (p = 0.005). In small bowel and lung NETs, 5-year cumulative incidences of severe (8.1% [95%CI 7.3-8.9%] vs. 7.0% [95%CI 6.3-7.8%]; p = 0.01) and other psychiatric illness (34.7% [95%CI 33.3-36.1%] vs. 31.1% [95%CI 29.7-32.5%]; p < 0.01) were higher than for matched CC. The same was observed for serotonin-producing NETs for both severe (7.9% [95%CI 6.5-9.4%] vs. 6.8% [95%CI 5.5-8.2%]; p = 0.02) and other psychiatric illness (35.4% [95%CI 32.8-38.1%] vs. 31.9% [95%CI 29.3-34.4%]; p = 0.02). In all NETs, there was no difference observed in the incidence of psychiatric illness compared to CC. For sub-groups of small bowel and lung NETs and of serotonin-producing NETs, the incidence of psychiatric illness was higher than for CC. These data suggest a signal towards a relationship between those sub-groups of NETs and psychiatric illness.
Identifiants
pubmed: 36197513
doi: 10.1007/s00520-022-07365-z
pii: 10.1007/s00520-022-07365-z
doi:
Substances chimiques
Serotonin
333DO1RDJY
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9635-9646Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Modlin IM, Oberg K, Chung DC et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9(61):72. https://doi.org/10.1016/s1470-2045(07)70410-2
doi: 10.1016/s1470-2045(07)70410-2
Zikusoka MN, Kidd M, Eick G et al (2005) The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 104:2292–2309. https://doi.org/10.1002/cncr.21451
doi: 10.1002/cncr.21451
pubmed: 16258976
Hallet J, Cukier M, Saskin R, Liu N (2015) Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 121(589):597. https://doi.org/10.1002/cncr.29099
doi: 10.1002/cncr.29099
Dasari A, Shen C, Halperin D et al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3(1335):8. https://doi.org/10.1001/jamaoncol.2017.0589
doi: 10.1001/jamaoncol.2017.0589
Russo S, Nielen MMA, Boon JC et al (2003) Neuropsychological investigation into the carcinoid syndrome. Psychopharmacology 168:324–328. https://doi.org/10.1007/s00213-003-1455-5
doi: 10.1007/s00213-003-1455-5
pubmed: 12695876
Shah GM, Shah RG, Veillette H et al (2005) Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol 100:2307–2314. https://doi.org/10.1111/j.1572-0241.2005.00268.x
doi: 10.1111/j.1572-0241.2005.00268.x
pubmed: 16181385
Pasieka JL, Longman RS, Chambers AJ et al (2014) Cognitive impairment associated with carcinoid syndrome. Ann Surg 259(355):359. https://doi.org/10.1097/sla.0b013e318288ff6d
doi: 10.1097/sla.0b013e318288ff6d
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356. https://doi.org/10.1002/cncr.25098
doi: 10.1002/cncr.25098
pubmed: 20564075
Cimprich B, Reuter-Lorenz P, Nelson J et al (2010) Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32:324–331. https://doi.org/10.1080/13803390903032537
doi: 10.1080/13803390903032537
pubmed: 19642048
Miller AH, Ancoli-Israel S, Bower JE et al (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26(971):982. https://doi.org/10.1200/jco.2007.10.7805
doi: 10.1200/jco.2007.10.7805
Scandurra C, Modica R, Maldonato NM et al (2021) Quality of life in patients with neuroendocrine neoplasms: the role of severity, clinical heterogeneity, and resilience. J Clin Endocrinol Metab 106:e316–e327. https://doi.org/10.1210/clinem/dgaa760
doi: 10.1210/clinem/dgaa760
pubmed: 33084861
Shah RK, Arjmand E, Roberson DW et al (2011) Variation in surgical time-out and site marking within pediatric otolaryngology. Archives Otolaryngol–Head Neck Surg 137:69–73. https://doi.org/10.1001/archoto.2010.232
doi: 10.1001/archoto.2010.232
Lehmann J (1982) Tryptophan deficiency stupor–a new psychiatric syndrome. Acta Psychiatr Scand Suppl 300(1):57
doi: 10.1111/j.1600-0447.1988.tb06301.x
Hanna SM (1965) Carcinoid syndrome associated with psychosis. Postgrad Med J 41:566–567. https://doi.org/10.1136/pgmj.41.479.566
doi: 10.1136/pgmj.41.479.566
pubmed: 5827675
pmcid: 2483048
Trivedi S (1984) Psychiatric symptoms in carcinoid syndrome. J Indian Med Assoc 82:292–294
pubmed: 6491341
Major LF, Brown GL, Wilson WP (1973) Carcinoid and psychiatric symptoms. South Med J 66(787):790
Benchimol EI, Smeeth L, Guttmann A et al (2015) The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 12(e1001885):22. https://doi.org/10.1371/journal.pmed.1001885
doi: 10.1371/journal.pmed.1001885
Canada H (2004) Canada Health Act. https://www.canada.ca/en/health-canada/services/health-care-system/canada-health-care-system-medicare/canada-health-act.html . Accessed 29 Feb 2020
Hallet J, Law CHL, Karanicolas PJ et al (2015) Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: a population-based analysis of 6271 cases. Cancer 121:2214–2221. https://doi.org/10.1002/cncr.29338
doi: 10.1002/cncr.29338
pubmed: 25823667
Hallet J, Law CHL, Cheung M et al (2017) Patterns and drivers of costs for neuroendocrine tumor care: a comparative population-based analysis. Ann Surg Oncol 24:3312–3323. https://doi.org/10.1245/s10434-017-5986-0
doi: 10.1245/s10434-017-5986-0
pubmed: 28695392
Robles SC, Marrett LD, Clarke EA, Risch HA (1988) An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41(495):501
Clarke EA, Marrett LD, Kreiger N (1991) Cancer registration in Ontario: a computer approach. IARC Sci Publ. 246 – 257.
Juurlink D, Preyra C, Croxford R Canadian institute for health information discharge abstract database: a validation study
Vigod SN, Dennis CL, Kurdyak PA et al (2014) Fertility rate trends among adolescent girls with major mental illness: a population-based study. Pediatrics 133:e585-591. https://doi.org/10.1542/peds.2013-1761
doi: 10.1542/peds.2013-1761
pubmed: 24515515
Kurdyak P, Lin E, Green D, Vigod S (2015) Validation of a population-based algorithm to detect chronic psychotic illness. Can J Psychiatry 60:362–368. https://doi.org/10.1177/070674371506000805
doi: 10.1177/070674371506000805
pubmed: 26454558
pmcid: 4542516
Mahar AL, Kurdyak P, Hanna TP et al (2020) The effect of a severe psychiatric illness on colorectal cancer treatment and survival: a population-based retrospective cohort study. PLoS One 15:e0235409. https://doi.org/10.1371/journal.pone.0235409
doi: 10.1371/journal.pone.0235409
pubmed: 32726314
pmcid: 7390537
Mahar AL, Kurdyak P, Hanna TP et al (2020) Cancer staging in individuals with a severe psychiatric illness: a cross-sectional study using population-based cancer registry data. BMC Cancer 20:476. https://doi.org/10.1186/s12885-020-06943-w
doi: 10.1186/s12885-020-06943-w
pubmed: 32460722
pmcid: 7251666
Ruggeri M, Leese M, Thornicroft G et al (2000) Definition and prevalence of severe and persistent mental illness. Br J Psychiatry 177:149–155. https://doi.org/10.1192/bjp.177.2.149
doi: 10.1192/bjp.177.2.149
pubmed: 11026955
Heggestad T, Lilleeng SE, Ruud T (2011) Patterns of mental health care utilisation: distribution of services and its predictability from routine data. Soc Psychiatry Psychiatr Epidemiol 46:1275–1282. https://doi.org/10.1007/s00127-010-0295-y
doi: 10.1007/s00127-010-0295-y
pubmed: 20938639
Kisely S, Forsyth S, Lawrence D (2016) Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? Aust N Z J Psychiatry 50:254–263. https://doi.org/10.1177/0004867415577979
doi: 10.1177/0004867415577979
pubmed: 25829481
Lora A, Bezzi R, Erlicher A (2007) Estimating the prevalence of severe mental illness in mental health services in Lombardy (Italy). Community Ment Health J 43:341–357. https://doi.org/10.1007/s10597-006-9078-z
doi: 10.1007/s10597-006-9078-z
pubmed: 17253144
Kralj B (2000) Measuring “rurality” for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev 67(33):52
Matheson FI, Dunn JR, Smith KLW et al (2012) Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health 103:S12-16
doi: 10.1007/BF03403823
pubmed: 23618065
pmcid: 6973681
Reid RJ, Roos NP, MacWilliam L et al (2002) Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the Province of Manitoba. Health Serv Res 37(1345):1364. https://doi.org/10.1111/1475-6773.01029
doi: 10.1111/1475-6773.01029
Weiner JP, Starfield BH, Steinwachs DM, Mumford LM (1991) Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 29:452–472. https://doi.org/10.1097/00005650-199105000-00006
doi: 10.1097/00005650-199105000-00006
pubmed: 1902278
Mahar AL, Jeong Y, Zagorski B, Coburn N (2018) Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data. BMC Health Serv Res 18:309. https://doi.org/10.1186/s12913-018-3125-7
doi: 10.1186/s12913-018-3125-7
pubmed: 29716600
pmcid: 5930789
Austin PC (2009) Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat-Simul Comput 38:1228–1234
doi: 10.1080/03610910902859574
Mamdani M, Sykora K, Li P et al (2005) Reader’s guide to critical appraisal of cohort studies: 2 Assessing potential for confounding. BMJ 330:960–962. https://doi.org/10.1136/bmj.330.7497.960
doi: 10.1136/bmj.330.7497.960
pubmed: 15845982
pmcid: 556348
Dignam JJ, Kocherginsky MN (2008) Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26:4027–4034. https://doi.org/10.1200/JCO.2007.12.9866
doi: 10.1200/JCO.2007.12.9866
pubmed: 18711194
pmcid: 2654314
Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141–1154
doi: 10.1214/aos/1176350951
Raison CL, Miller AH (2003) Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54:283–294. https://doi.org/10.1016/s0006-3223(03)00413-x
doi: 10.1016/s0006-3223(03)00413-x
pubmed: 12893104
McDaniel JS, Musselman DL, Porter MR et al (1995) Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89–99. https://doi.org/10.1001/archpsyc.1995.03950140007002
doi: 10.1001/archpsyc.1995.03950140007002
pubmed: 7848055
Chiruvella A, Kooby DA (2016) Surgical management of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am 25:401–421. https://doi.org/10.1016/j.soc.2015.12.002
doi: 10.1016/j.soc.2015.12.002
pubmed: 27013372
Mirakhur B, Pavel ME, Pommier RF, et al (2018) Biochemical responses in symptomatic and asymptomatic patients with neuroendocrine tumors: pooled analysis of 2 phase 3 trials. Endocr Pract. https://doi.org/10.4158/EP-2018-0296
Bender DA (1983) Biochemistry of tryptophan in health and disease. Mol Aspects Med 6:101–197. https://doi.org/10.1016/0098-2997(83)90005-5
doi: 10.1016/0098-2997(83)90005-5
pubmed: 6371429
Hallet J, Davis LE, Isenberg-Grzeda E et al (2020) Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes. Oncologist 25:e1098–e1108. https://doi.org/10.1634/theoncologist.2019-0709
doi: 10.1634/theoncologist.2019-0709
pubmed: 32100906
pmcid: 7356756
Hallet J, Davis LE, Mahar AL, (10, et al (2019) Patterns of symptoms burden in neuroendocrine tumors: a population-based analysis of prospective patient-reported outcomes. Oncologist 24:1384–1394. https://doi.org/10.1634/theoncologist.2019-0112
doi: 10.1634/theoncologist.2019-0112
pubmed: 31270268
pmcid: 6795154
Holland JC, Bultz BD, National Comprehensive Cancer Network (NCCN) (2007) the NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 5:3–7
doi: 10.6004/jnccn.2007.0003
pubmed: 17323529
Bultz BD, Groff SL, Fitch M et al (2011) Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 20(463):469. https://doi.org/10.1002/pon.1932
doi: 10.1002/pon.1932
Davis LE, Bogner E, Coburn NG et al (2020) Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis. J Epidemiol Community Health 74:84–94. https://doi.org/10.1136/jech-2019-212311
doi: 10.1136/jech-2019-212311
pubmed: 31653661